{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:17:28Z","timestamp":1787977048453,"version":"build-2784847793"},"reference-count":59,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.8200-26","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:12:03Z","timestamp":1787609523000},"source":"Crossref","is-referenced-by-count":0,"title":["Life Course Immunization in Japan: A Practice-Oriented Framework for Internal Medicine"],"prefix":"10.2169","author":[{"given":"Katsunori","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Infectious Disease Medicine, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Machida M, Fukushima S, Saitoh A, Inoue S, Tabuchi T. Uptake among four indicated vaccines by adults aged 65 years and older in Japan, 2023. Vaccine 42: 125985, 2024.","DOI":"10.1016\/j.vaccine.2024.05.033"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kim Y, Taniguchi H, Okuyama K, Kawakami K. Coverage rates and reasons for pneumococcal vaccination among adults with chronic medical conditions and the elderly in Japan: A web-based, cross-sectional study. BMJ Open 15: e098133, 2025.","DOI":"10.1136\/bmjopen-2024-098133"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tanaka T, Kakiuchi S, Fujita A, Tashiro M, Izumikawa K. Vaccination strategies for transplantation in Japan: solid organ transplantation and hematopoietic stem cell transplantation. J Infect Chemother 31: 102772, 2025.","DOI":"10.1016\/j.jiac.2025.102772"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hill JA, Boonyaratanakornkit J, Mikulska M, et al. Innovation in active and passive immunisation of people who are immunocompromised: a call to action. Lancet Infect Dis 26: e16-e29, 2026.","DOI":"10.1016\/S1473-3099(25)00345-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wallace AS, Ryman TK, Privor-Dumm L, et al. Leaving no one behind: Defining and implementing an integrated life course approach to vaccination across the next decade as part of the Immunization Agenda 2030. Vaccine 42 (Suppl 1): S54-S63, 2024.","DOI":"10.1016\/j.vaccine.2022.11.039"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lindstrand A, Cherian T, Chang-Blanc D, Feikin D, O\u2019Brien KL. The world of immunization: achievements, challenges, and strategic vision for the next decade. J Infect Dis 224 (12 Suppl 2): S452-S467, 2021.","DOI":"10.1093\/infdis\/jiab284"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Balsells E, Ghiselli M, Hommes C, et al. Rethinking immunization programs through the life course approach. Front Public Health 12: 1355384, 2024.","DOI":"10.3389\/fpubh.2024.1355384"},{"key":"8","unstructured":"8. Greenberg GM, Koshy PA, Hanson MJS. Adult vaccination. Am Fam Physician 106: 534-542, 2022."},{"key":"9","unstructured":"9. Centers for Disease Control and Prevention. Adult Immunization Schedule by Age, United States, 2025. Advisory Committee on Immunization Practices [Internet]. [cited 2026 Jul 13]. Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-schedules\/adult-age.html"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hunter P, Fryhofer SA, Szilagyi PG. Vaccination of adults in general medical practice. Mayo Clin Proc 95: 169-183, 2020.","DOI":"10.1016\/j.mayocp.2019.02.024"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Bridges CB, Hurley LP, Williams WW, et al. Meeting the challenges of immunizing adults. Am J Prev Med 49 (6 Suppl 4): S455-S464, 2015.","DOI":"10.1016\/j.amepre.2015.08.014"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wheeler SG, Beste LA, Overland MK, Wander PL. Interventions in primary care to increase uptake of adult vaccines: a systematic review. J Public Health (Oxf) 47: 222-231, 2025.","DOI":"10.1093\/pubmed\/fdaf008"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Saitoh A, Okabe N. Current issues with the immunization program in Japan: can we fill the \u201cvaccine gap\u201d? Vaccine 30: 4752-4756, 2012.","DOI":"10.1016\/j.vaccine.2012.04.026"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Saitoh A, Okabe N. Progress and challenges for the Japanese immunization program: Beyond the \u201cvaccine gap\u201d. Vaccine 36: 4582-4588, 2018.","DOI":"10.1016\/j.vaccine.2018.01.092"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kamiya H, Kamidani S, Saitoh A. An introduction to the Japanese immunization program: past, present, and future perspectives. Pediatr Infect Dis J 42: e154-e157, 2023.","DOI":"10.1097\/INF.0000000000003854"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kawakami K, Nakamura A, Wakana A, Folaranmi TA, Iino T. A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine coverage among patients with chronic medical conditions aged 50 and older. Hum Vaccin Immunother 16: 1521-1528, 2020.","DOI":"10.1080\/21645515.2019.1690332"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Saitoh A, Okabe N. Changes and remaining challenges for the Japanese immunization program: closing the vaccine gap. Vaccine 39: 3018-3024, 2021.","DOI":"10.1016\/j.vaccine.2021.04.023"},{"key":"18","unstructured":"18. Ministry of Health, Labour and Welfare, Japan. Vaccines for adults aged 65 years and older [Internet]. [cited 2026 Jul 13]. Available from: https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/kenkou\/kekkaku-kansenshou\/yobou-sesshu\/vaccine\/years-65.html"},{"key":"19","unstructured":"19. Ministry of Health, Labour and Welfare, Japan. Herpes zoster vaccine [Internet]. [cited 2026 Jul 13]. Available from: https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/kenkou\/kekkaku-kansenshou\/yobou-sesshu\/vaccine\/shingles\/index.html"},{"key":"20","unstructured":"20. Ministry of Health, Labour and Welfare, Japan. Pneumococcal vaccine for older adults [Internet]. [cited 2026 Jul 13]. Available from: https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/kenkou\/kekkaku-kansenshou\/yobou-sesshu\/vaccine\/pneumococcus-senior\/index.html"},{"key":"21","unstructured":"21. Ministry of Health, Labour and Welfare, Japan. Additional measures against rubella [Internet]. [cited 2026 Jul 13]. Available from: https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/kenkou\/kekkaku-kansenshou\/rubella\/index_00001.html"},{"key":"22","unstructured":"22. Ministry of Health, Labour and Welfare, Japan. Digitalization of vaccination administration [Internet]. [cited 2026 Jul 13]. Available from: https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/kenkou\/kekkaku-kansenshou\/yobou-sesshu\/vaccine\/digital_kokumin.html"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Whitaker JA. Immunization strategies to span the spectrum of immunocompromised adults. Mayo Clin Proc 95: 1530-1548, 2020.","DOI":"10.1016\/j.mayocp.2019.09.002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Jiang G, Zou Y, Zhao D, Yu J. Optimising vaccine immunogenicity in ageing populations: key strategies. Lancet Infect Dis 25: e23-e33, 2025.","DOI":"10.1016\/S1473-3099(24)00497-3"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yamamoto K, Suzuki M, Ujiie M, Kanagawa S, Ohmagari N. Catch-up immunization for adolescents and young adults during pre-travel consultation in Japan. PLoS One 16: e0258357, 2021.","DOI":"10.1371\/journal.pone.0258357"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Freedman DO, Chen LH, Kozarsky PE. Medical considerations before international travel. N Engl J Med 375: 247-260, 2016.","DOI":"10.1056\/NEJMra1508815"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Udell JA, Zawi R, Bhatt DL, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 310: 1711-1720, 2013.","DOI":"10.1001\/jama.2013.279206"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Behrouzi B, Bhatt DL, Cannon CP, et al. Association of influenza vaccination with cardiovascular risk: a meta-analysis. JAMA Netw Open 5: e228873, 2022.","DOI":"10.1001\/jamanetworkopen.2022.8873"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Criner GJ, Bourbeau J, Diekemper RL, et al. Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society guideline. Chest 147: 894-942, 2015.","DOI":"10.1378\/chest.14-1676"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Li Y, Zhang P, An Z, et al. Effectiveness of influenza and pneumococcal vaccines on chronic obstructive pulmonary disease exacerbations. Respirology 27: 844-853, 2022.","DOI":"10.1111\/resp.14309"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Krueger KM, Ison MG, Ghossein C. Practical guide to vaccination in all stages of CKD, including patients treated by dialysis or kidney transplantation. Am J Kidney Dis 75: 417-425, 2020.","DOI":"10.1053\/j.ajkd.2019.06.014"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Girndt M. Vaccinations to prevent infections in adult individuals with CKD and after kidney transplantation: a review. Am J Kidney Dis 87: 841-851, 2026.","DOI":"10.1053\/j.ajkd.2025.10.021"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Bass AR, Chakravarty E, Akl EA, et al. 2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases. Arthritis Care Res (Hoboken) 75: 449-464, 2023.","DOI":"10.1002\/acr.25045"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Curtis JR, Johnson SR, Anthony DD, et al. American College of Rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: Version 5. Arthritis Rheumatol 75: E1-E16, 2023.","DOI":"10.1002\/art.42372"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Farraye FA, Melmed GY, Lichtenstein GR, et al. ACG clinical guideline update: Preventive care in inflammatory bowel disease. Am J Gastroenterol 120: 1447-1473, 2025.","DOI":"10.14309\/ajg.0000000000003541"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Leong RW, Sakiris A, Arzivian A, et al. Consensus statements on assessments and vaccinations prior to commencement of advanced therapies for the treatment of inflammatory bowel diseases. Aliment Pharmacol Ther 61: 132-144, 2025.","DOI":"10.1111\/apt.18318"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Kamboj M, Bohlke K, Baptiste DM, et al. Vaccination of adults with cancer: ASCO guideline. J Clin Oncol 42: 1699-1721, 2024.","DOI":"10.1200\/JCO.24.00032"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Cordonnier C, Einarsdottir S, Cesaro S, et al. Vaccination of haemopoietic stem cell transplant recipients: Guidelines of the 2017 European Conference on Infections in Leukaemia. Lancet Infect Dis 19: e200-e212, 2019.","DOI":"10.1016\/S1473-3099(18)30600-5"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Schoevaerdts D, Sibille FX, Gavazzi G. Infections in the older population: what do we know? Aging Clin Exp Res 33: 689-701, 2021.","DOI":"10.1007\/s40520-019-01375-4"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Laurent M, Oubaya N, David JP, et al. Functional decline in geriatric rehabilitation ward: Is it ascribable to hospital-acquired infection? a prospective cohort study. BMC Geriatr 20: 433, 2020.","DOI":"10.1186\/s12877-020-01813-3"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Cunningham AL, McIntyre P, Subbarao K, Booy R, Levin MJ. Vaccines for older adults. BMJ 372: n188, 2021.","DOI":"10.1136\/bmj.n188"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. American College of Obstetricians and Gynecologists\u2019 Committee on Gynecologic Practice; American Society for Reproductive Medicine. ACOG Committee Opinion No. 762: Prepregnancy counseling. Obstet Gynecol 133: e78-e89, 2019.","DOI":"10.1097\/AOG.0000000000003013"},{"key":"43","unstructured":"43. Paladine HL, Ekanadham H, Diaz DC. Health maintenance for women of reproductive age. Am Fam Physician 103: 209-217, 2021."},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. American College of Obstetricians and Gynecologists. Maternal immunizations. Committee Statement No. 26. Obstet Gynecol 147: e123-e128, 2026.","DOI":"10.1097\/AOG.0000000000006230"},{"key":"45","unstructured":"45. Ministry of Health, Labour and Welfare, Japan. Respiratory syncytial virus vaccine [Internet]. [cited 2026 Jul 13]. Available from: https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/kenkou\/kekkaku-kansenshou\/yobou-sesshu\/vaccine\/rs\/index.html"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Maltezou HC, Botelho-Nevers E, Brants\u00e6ter AB, et al. Vaccination of healthcare personnel in Europe: update to current policies. Vaccine 37: 7576-7584, 2019.","DOI":"10.1016\/j.vaccine.2019.09.061"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Swift MD, Behrman AJ. Vaccines for health care personnel. Mayo Clin Proc 94: 2127-2141, 2019.","DOI":"10.1016\/j.mayocp.2019.01.035"},{"key":"48","unstructured":"48. American College of Occupational and Environmental Medicine. ACOEM statement on adult immunization [Internet]. [cited 2026 Jul 13]. Available from: https:\/\/acoem.org\/acoem\/media\/PDF-Library\/ACOEM-Vaccine-Policy-Statement-Final-01-18-24.pdf"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Deal A, Halliday R, Crawshaw AF, et al. Migration and outbreaks of vaccine-preventable disease in Europe: a systematic review. Lancet Infect Dis 21: e387-e398, 2021.","DOI":"10.1016\/S1473-3099(21)00193-6"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Crawshaw AF, Farah Y, Deal A, et al. Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review. Lancet Infect Dis 22: e254-e266, 2022.","DOI":"10.1016\/S1473-3099(22)00066-4"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Crawshaw AF, Goldsmith LP, Deal A, et al. Driving delivery and uptake of catch-up vaccination among adolescent and adult migrants in UK general practice: a mixed methods pilot study. BMC Med 22: 186, 2024.","DOI":"10.1186\/s12916-024-03378-z"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Yasuhara N, Okamoto S, Hamada M, et al. Evaluation of Japanese people\u2019s perception of risk information for making decisions to receive influenza and rubella vaccinations. Health Expect 24: 2013-2022, 2021.","DOI":"10.1111\/hex.13342"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Nicholls LAB, Gallant AJ, Cogan N, et al. Older adults\u2019 vaccine hesitancy: psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake. Vaccine 39: 3520-3527, 2021.","DOI":"10.1016\/j.vaccine.2021.04.062"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Lu PJ, Srivastav A, Amaya A, et al. Association of provider recommendation and offer and influenza vaccination among adults aged \u226518 years\u2014United States. Vaccine 36: 890-898, 2018.","DOI":"10.1016\/j.vaccine.2017.12.016"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Hurley LP, Lindley MC, Allison MA, et al. Physicians\u2019 use of evidence-based strategies to increase adult vaccination uptake. Am J Prev Med 59: e95-e103, 2020.","DOI":"10.1016\/j.amepre.2020.03.020"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Buja A, Grotto G, Taha M, Cocchio S, Baldo V. Use of information and communication technology strategies to increase vaccination coverage in older adults: a systematic review. Vaccines (Basel) 11: 1274, 2023.","DOI":"10.3390\/vaccines11071274"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Dumit EM, Novillo-Ortiz D, Contreras M, Velandia M, Danovaro-Holliday MC. The use of eHealth with immunizations: an overview of systematic reviews. Vaccine 36: 7923-7928, 2018.","DOI":"10.1016\/j.vaccine.2018.06.076"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Kempe A, Lindley MC, O\u2019Leary ST, et al. Shared clinical decision-making recommendations for adult immunization: what do physicians think? J Gen Intern Med 36: 2283-2291, 2021.","DOI":"10.1007\/s11606-020-06456-z"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Sanftenberg L, Kuehne F, Anraad C, et al. Assessing the impact of shared decision-making processes on influenza vaccination rates in adult patients in outpatient care: a systematic review and meta-analysis. Vaccine 39: 185-196, 2021.","DOI":"10.1016\/j.vaccine.2020.12.014"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_8200-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:31:59Z","timestamp":1787974319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_8200-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":59,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8200-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"8200-26"}}